|
Зуклопентиксола ацетат (клопиксол-акуфаз)- аннотация
Новые возможности лечения психически больных (обзор иностранной литературы). Н. Б. Жаркова, Г. И. Копейко, А. А. Мухин. НЦПЗ РАМН, Москва.Психиатрия и психофармакотерапия N1/1999
Long-acting antipsychotic medication, restraint and treatment in the management of acute psychosis Paul Fitzgeraldpdf
Zuclopenthixol acetate in psychiatric emergencies looking for evidence from clinical trials Evandro Coutinho, Mark Fenton, Clive Adams, Colin Campbell. Schizophrenia Research vol 46, 2000, 111-118/ Elseverpdf
Economic evaluation of zuclopenthixol acetate compared with injectable haloperidol in schizophrenic patients with acute psychosis Claudine Laurier, Wendy Kennedy, Jean Lachaine, Line Gariepy and Geneviev Tessier. Clinical Therapeutics Vol 19, no 2, 1997, pp. 316-329pdf
Pharmacokinetics of three different injectable zuclopenthixol preparations Tove Aaes-Jorgensen. Prog. Neuro-Psychopharmacol. & Biol. Psychiat. 1989 Vol 13, pp 77-85. pdf
Long-acting antipsychotic medication, restraint and treatment in the management of acute psychosis Paul Fitzgerald. Australian and New Zealand Journal of Psychiatry Volume 33, Issue 5, Page 660-666, Oct 1999 pdf
The development of Clinical Guidelines for the use of Zuclopenthixol Acetate Caryl W Barnes, Deirdre Alderton, David Castle Australasian Psychiatry Volume 10, Issue 1, Page 54-58, Apr 2002 pdf
|
